Beauty Health Clocks 13% Growth In Q2 Revenues On Strong Demand For Hydrafacial
Portfolio Pulse from Nabaparna Bhattacharya
The Beauty Health Company (NASDAQ:SKIN) reported Q2 revenues of $117.5 million, up 13% Y/Y, beating the consensus of $116.08 million. The growth was driven by strong demand for Hydrafacial and strength in consumables. However, Q2 EPS of $0.03 missed the analyst consensus of $0.05. The company also announced the appointment of a new CFO, Michael Monahan, effective August 10, 2023. SKIN shares are trading lower by 0.27% to $7.51.
August 09, 2023 | 3:46 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
The Beauty Health Company's Q2 revenues beat consensus, but EPS missed estimates. The company also announced the appointment of a new CFO. The stock is trading lower.
The Beauty Health Company reported strong Q2 revenues, driven by high demand for its Hydrafacial product. However, the company's EPS missed analyst estimates, which could negatively impact investor sentiment. The appointment of a new CFO could also introduce uncertainty. The stock is currently trading lower, indicating a negative short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100